INS and metabolic dysfunction-associated steatotic liver disease: Estrogen decline favors the development and progression of non-alcoholic fatty liver disease in postmenopausal women because of decreased insulin sensitivity, mitochondrial dysfunction, increased inflammation, and fibrogenesis [36].